BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37783639)

  • 1. Creating Equitable and Inclusive Clinical Trials for Multiple Myeloma.
    Hartley-Brown M; Cole CE; Price P; Andreini M; Mulligan G; Young AQ; Cho HJ
    Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):32-39. PubMed ID: 37783639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culturally Responsive Care Delivery in Oncology: The Example of Multiple Myeloma.
    Blue B; Pierre A; Mikhael J
    Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):651-659. PubMed ID: 37290997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.
    Neffa-Creech D; Aggarwal R; Stowell C; Menon U; George S; Plant A; Langbaum JB
    J Prev Alzheimers Dis; 2023; 10(4):865-874. PubMed ID: 37874109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?
    Aung TN; Bickell NA; Jagannath S; Kamath G; Meltzer J; Kunzel B; Egorova NN
    Am J Clin Oncol; 2021 Dec; 44(12):603-612. PubMed ID: 34753885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic underrepresentation in dermatology clinical trials.
    Mineroff J; Nguyen JK; Jagdeo J
    J Am Acad Dermatol; 2023 Aug; 89(2):293-300. PubMed ID: 37062462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcare.
    Gormley N; Fashoyin-Aje L; Locke T; Unger JM; Little RF; Nooka A; Mezzi K; Popa-McKiver M; Kobos R; Biru Y; Williams TH; Anderson KC
    Blood Cancer Discov; 2021 Mar; 2(2):119-124. PubMed ID: 34179821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and Ethnicity Reporting and Representation in Pediatric Clinical Trials.
    Brewster RCL; Steinberg JR; Magnani CJ; Jackson J; Wong BO; Valikodath N; MacDonald J; Li A; Marsland P; Goodman SN; Schroeder A; Turner B
    Pediatrics; 2023 Apr; 151(4):. PubMed ID: 36916197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials.
    Reid MM; Davis SP; Henry ON; Mathew AA; McCallister S; Nero TT; Rabheru SA; Sampson SH; Vanderslice TF; Williams DT
    Clin Trials; 2023 Apr; 20(2):133-144. PubMed ID: 36744680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
    Allison K; Patel DG; Greene L
    JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equitable Representation of Latinos in Clinical Research Is Needed to Achieve Health Equity in Cancer Care.
    Ramirez AG; Chalela P
    JCO Oncol Pract; 2022 May; 18(5):e797-e804. PubMed ID: 35544655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic diversity of participants in Pfizer sponsored clinical trials in the United States.
    Rottas M; Thadeio P; Simons R; Houck R; Gruben D; Keller D; Scholfield D; Soma K; Corrigan B; Schettino A; McCann PJ; Hellio MP; Natarajan K; Goodwin R; Sewards J; Honig P; MacKenzie R
    Contemp Clin Trials; 2021 Jul; 106():106421. PubMed ID: 33940253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ensuring that the fruits of clinical trial research translate to equitable care.
    Vickrey BG; Koroshetz WJ
    Neurology; 2011 Jan; 76(4):314-5. PubMed ID: 21209371
    [No Abstract]   [Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing methods in the ELEGANCE registry to increase diversity in clinical research.
    Secemsky EA; Giri J; Brodmann M; Gouëffic Y; Fu W; Greenberg-Worisek AJ; Jaff MR; Kirksey L; Kohi MP
    J Vasc Surg; 2024 Jan; 79(1):136-145.e3. PubMed ID: 37742734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
    Alqazaqi R; Schinke C; Thanendrarajan S; Zangari M; Shaughnessy J; Zhan F; Tricot G; van Rhee F; Al Hadidi S
    JAMA Netw Open; 2022 Aug; 5(8):e2228877. PubMed ID: 36018590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the recruitment of Hispanic/Latinx American older adults in clinical trials in the United States: A scoping review.
    Rodriguez DK; Hewage SA; Periyakoil VS
    J Am Geriatr Soc; 2023 Jun; 71(6):1974-1991. PubMed ID: 37013348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials.
    Ford JG; Howerton MW; Bolen S; Gary TL; Lai GY; Tilburt J; Gibbons MC; Baffi C; Wilson RF; Feuerstein CJ; Tanpitukpongse P; Powe NR; Bass EB
    Evid Rep Technol Assess (Summ); 2005 Jun; (122):1-11. PubMed ID: 15989377
    [No Abstract]   [Full Text] [Related]  

  • 18. Identifying the barriers and perceptions of non-Hispanic black and Hispanic/Latino persons with uncontrolled type 2 diabetes for participation in a home Telemonitoring feasibility study: a quantitative analysis of those who declined participation, withdrew or were non-adherent.
    Tong T; Myers AK; Bissoonauth AA; Pekmezaris R; Kozikowski A
    Ethn Health; 2020 May; 25(4):485-494. PubMed ID: 30644784
    [No Abstract]   [Full Text] [Related]  

  • 19. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
    Lolic M; Araojo R; Okeke M; Temple R
    J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formative research to design a culturally-appropriate cancer clinical trial education program to increase participation of African American and Latino communities.
    Cunningham-Erves J; Barajas C; Mayo-Gamble TL; McAfee CR; Hull PC; Sanderson M; Canedo J; Beard K; Wilkins CH
    BMC Public Health; 2020 Jun; 20(1):840. PubMed ID: 32493245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.